G Medical Innovations Holdings Ltd
Change company Symbol lookup
Select an option...
GMVD G Medical Innovations Holdings Ltd
CMPX Compass Therapeutics Inc.
AMST Amesite Inc
AMPX Amprius Technologies Inc
PRTK Paratek Pharmaceuticals Inc
EGRAY Energy Resources Of Australia Ltd
IVAC Intevac Inc
PFE Pfizer Inc
BNOX Bionomics Ltd
CRKN Crown Electrokinetics Corp.
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Health Care Providers & Services | Small Cap Value
Based in Cayman Islands

G Medical Innovations Holdings Ltd. is a mobile health (mHealth) and e-health company. The Company is focused on the development of mHealth and telemedicine solutions and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. Its product lines consist of its Prizma medical device, a clinical grade device that can transform any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data continuously, including its QT Prolongation Syndrome Detection Capabilities Patch. Its monitoring services include the provision of independent diagnostic testing facilities and private monitoring services. It also develops wireless vital signs monitoring systems.

Closing Price: $0.91

Day's Change: -0.75 (-45.18%)

Bid: --

Ask: --

B/A Size: --

Day's High: 3.13

Day's Low: 0.89

Volume (Heavy Day) Volume: 14,375,129 10-day average volume: 1,803,160: 14,375,129

Broadcom's $61 billion purchase of VMware draws investigation from U.K. regulators

6:20 am ET January 25, 2023 (MarketWatch) Print

The U.K.'s Competition and Markets Authority said Wednesday that it was investigating Broadcom Inc.'s (AVGO) planned $61 billion purchase of VMware Inc. (VMW) The CMA disclosed in a press release that the deadline for a phase 1 decision is March 22, though the agency isn't guaranteeing that a decision will be announced by then. The European Commission is also looking into the merger, it announced in December, citing the possibility that the deal "would allow Broadcom to restrict competition in the market for certain hardware components which interoperate with VMware's software."

-Emily Bary

(END) Dow Jones Newswires

January 25, 2023 06:20 ET (11:20 GMT)

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and